Gary C Starling

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 2

Top Topics

Methicillin Resistant Staphylococcus Aureus

Pluripotent Stem Cells

Monoclonal Antibody

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of immunology research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Beth Hutchins, Gary C Starling, Mark A McCoy, Danuta Herzyk, Frederique M Poulet, John Dulos, Liming Liu, Soonmo Peter Kang, Laurence Fayadat-Dilman, Mark Hsieh, Christine L Andrews, Gulesi Ayanoglu, Constance Cullen, Rene de Waal Malefyt, Robert A Kastelein, Sabine Le Saux, Julie Lee, Sophie Li, Dan Malashock, Svetlana Sadekova, Gregory J Carven, Hans van Eenennaam, Aarron Willingham, Ying Yu, Michel Streuli, Andrea van Elsas
Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab. Molecular cancer therapeutics 19 (6) (2020)
Shiming Ye, Melvin I Fox, Nicole A Belmar, Mien Sho, Debra T Chao, Donghee Choi, Yuni Fang, Vivian Zhao, Stephen F Keller, Gary C Starling, Patricia A Culp
Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells. Journal of immunology research 2017 (2017)